Volume 85, Supplement 1, October 2019 ISSN 0145-2126 Supplement Abstracts of the Xth Eurasian Hematology Oncology Congress 8–11 October 2019 Istanbul, Turkey Editor-in-Chief Clive S. Zent USA Associate Editors Karl-Anton Kreuzer Germany David Ross Australia Publication of this abstract book is sponsored by the Eurasian Hematology Oncology Congress Supplement Abstracts of the Xth Eurasian Hematology Oncology Congress 8–11 October 2019, Istanbul, Turkey EHOC 2019 Publication of this abstract book is sponsored by the Eurasian Hematology Oncology Congress Symposium abstracts are published as submitted or with minor editing only. Leukemia Research is not responsible for errors or omissions in the abstracts. AMSTERDAM x BOSTON x LONDON x NEW YORK x OXFORD x PARIS x PHILADELPHIA x SAN DIEGO x ST. LOUIS Published monthly Storage or Usage Publication information: Leukemia Research (ISSN 0145-2126). For 2019, Except as outlined above or as set out in the relevant user license, no part of volumes 77–88 (12 issues) are scheduled for publication. Subscription prices are this publication may be reproduced, stored in a retrieval system or transmitted available upon request from the Publisher or from the Elsevier Customer Service in any form or by any means, electronic, mechanical, photocopying, recording Department nearest you or from this journal’s website (http://intl.elsevierhealth. or otherwise, without prior written permission of the publisher. com/journals/lere). Further information is available on this journal and other Elsevier products through Elsevier’s website: (http://www.elsevier.com). Permissions Subscriptions are accepted on a prepaid basis only and are entered on a calendar For information on how to seek permission visit www.elsevier.com/ year basis. Issues are sent by standard mail (surface within Europe, air delivery permissions or call: (+44) 1865 843830 (UK) / (+1) 215 239 3804 (USA). outside Europe). Priority rates are available upon request. Claims for missing Author rights issues should be made within six months of the date of dispatch. Author(s) may have additional rights in their articles as set out in their agreement Advertising information. Advertising orders and inquiries can be sent to: with the publisher (more information at http://www.elsevier.com/authorsrights). Nicholas Dunwell, Account Executive, Elsevier Ltd. 32 Jamestown Road, Language (Usage and Editing services) London, NW1 7BY, UK Tel.: +44 (0) 20 7424 4383 Fax: +44 (0) 20 7424 4433 Please write your text in good English (American or British usage is accepted, Email: [email protected]. For inquiries relating to Commercial Sales but not a mixture of these). Authors who feel their English language and Supplements please contact: Eva Nagtegaal, Account Manager, Conference manuscript may require editing to eliminate possible grammatical or spelling Information Publishing Elsevier B.V. Radarweg 29 Amsterdam 1043 NX errors and to conform to correct scientific English may wish to use the English Netherlands Tel.: +31 20 485 3984 Fax: 0031 20 485 2940 Email: e.nagtegaal@ Language Editing service available from Elsevier’s WebShop http://webshop. elsevier.com elsevier.com/languageediting/ or visit our customer support site http:// USA mailing notice: Leukemia Research (ISSN 0145-2126) is published service.elsevier.com for more information. monthly by Elsevier Ltd (The Boulevard, Langford Lane, Kidlington, Oxford Illustration services OX5 1GB, UK). Periodicals postage paid at Jamaica, NY 11431 and additional Elsevier’s WebShop (http://webshop.elsevier.com/illustrationservices) offers mailing offices. Illustration Services to authors preparing to submit a manuscript but concerned USA POSTMASTER: Send change of address to Leukemia Research, Elsevier about the quality of the images accompanying their article. Elsevier’s expert Customer Service Department, 3251 Riverport Lane, Maryland Heights, MO illustrators can produce scientific, technical and medical-style images, as well 63043, USA. as a full range of charts, tables and graphs. Image ‘polishing’ is also available, AIRFREIGHT AND MAILING in USA by Air Business Ltd., c/o Worldnet Shipping where our illustrators take your image(s) and improve them to a professional Inc, 156-15, 146th Avenue, 2nd Floor, Jamaica, NY 11434, USA. standard. Please visit the website to find out more. Aims and Scope Notice leukemia Research is an international journal which brings comprehensive Practitioners and researchers must always rely on their own experience and and current information to all health care professionals involved in basic and knowledge in evaluating and using any information, methods, compounds (or) applied clinical research in leukemias, lymphomas, multiple myeloma or experiments described herein. Because of rapid advances in the medical and other hematologic malignancies. The editors encourage the submission sciences, in particular, independent verification of diagnoses and drug dosages of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell should be made. To the fullest extent of the law, no responsibility is assumed by biology, immunology and molecular biology as well as epidemiologic and the publisher for any injury and/or damage to persons or property as a matter clinical studies. of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation Although all advertising material is expected to conform to ethical (medical) agents, novel therapeutics and clinical trials in both the acute and chronic standards, inclusion in this publication does not constitute a guarantee or leukemias as well as the myelodysplastic syndromes. In addition, we solicit endorsement of the quality or value of such product or of the claims made of selected articles on the rapidly increasing specialty of marrow or stem cell it by its manufacturer. reconstitution after high dose therapy with curative attempt in patients with Author inquiries a wide range of neoplasms. You can track your submitted article at http://www.elsevier.com/track- © 2019 Elsevier Ltd. submission. You can track your accepted article at http://www.elsevier.com/ trackarticle. You are also welcome to contact Customer Support via http:// This journal and the individual contributions contained in it are protected service.elsevier.com under copyright, and the following terms and conditions apply to their use in addition to the terms of any Creative Commons or other user license that has Guide for Authors been applied by the publisher to an individual article: For a full and complete Guide for Authors, please go to http://www.elsevier. com/locate/leukres or http://ees.elsevier.com/lr/ Photocopying Single photocopies of single articles may be made for personal use Orders, claims, and journal inquiries: please contact the Elsevier Customer as allowed by national copyright laws. Permission is not required for Service Department nearest you: photocopying of articles published under the CC BY license nor for St. Louis: Elsevier Customer Service Department, 3251 Riverport Lane, photocopying for non-commercial purposes in accordance with any other Maryland Heights, MO 63043, USA; phone: (877) 6542452 [toll free within the user license applied by the publisher. Permission of the publisher and USA]; (+1) (314) 4478871 [outside the USA]; fax: (+1) (314) 4478029; e-mail: payment of a fee is required for all other photocopying, including multiple [email protected] or systematic copying, copying for advertising or promotional purposes, Oxford: Elsevier Customer Service Department, The Boulevard, Langford Lane, resale, and all forms of document delivery. Special rates are available for Kidlington, Oxford OX5 1GB, UK; phone: (+44) (1865) 843434; fax: (+44) educational institutions that wish to make photocopies for non-profit (1865) 843970; e-mail: [email protected] educational classroom use. Tokyo: Elsevier Customer Service Department, 4F Higashi-Azabu, 1-Chome Bldg, Derivative Works 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; phone: (+81) (3) Users may reproduce tables of contents or prepare lists of articles including 5561 5037; fax: (+81) (3) 5561 5047; e-mail: JournalsCustomerServiceJapan@ abstracts for internal circulation within their institutions or companies. Other elsevier.com than for articles published under the CC BY license, permission of the publisher is required for resale or distribution outside the subscribing institution or Singapore: Elsevier Customer Service Department, 3 Killiney Road, #08-01 company. Winsland House I, Singapore 239519; phone: (+65) 63490222; fax: (+65) 67331510; e-mail: [email protected] For any subscribed articles or articles published under a CC BY-NC-ND license, ϱ permission of the publisher is required for all other derivative works, including The paper used in this publication meets the requirements of ANSI/NISO compilations and translations. Z39.48-1992 (Permanence of Paper) EDITOR-IN-CHIEF Clive S. Zent, University of Rochester Medical Center, Rochester, NY, USA ASSOCIATE EDITORS Karl-Anton Kreuzer, Universität zu Köln, Cologne, Germany David Ross, Flinders Medical Centre, South Australia, Australia EDITORIAL OFFICE email: [email protected] EDITORIAL BOARD I. Abraham, USA Q. Jiang, China A.